sources posts | ILife Consulting

top of page

Testimonials

ImCheck Therapeutics | Paul Frohna, CMO

02:34

ImCheck Therapeutics | Paul Frohna, CMO

ImCheck Therapeutics is designing and developing novel immunotherapeutics that target members of the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules with an initial focus on gamma delta (γ9δ2) T cells. Interview with Paul Frohna, Chief Medical Officer

Smart Immune | Karine Rossignol, CEO

02:55

Smart Immune | Karine Rossignol, CEO

Smart Immune is a clinical-stage biotechnology company developing ProTcell™a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next generation allogeneic T-cell therapies for all. Interview with Karine Rossignol, CEO and co-founder

Carthera | Carole Desseaux, CCO

02:57

Carthera | Carole Desseaux, CCO

Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Interview with Carole Desseaux, Chief Clinical Officer

Case studies

Testimonial of a CRA monitoring trials in Spain

CRA testimonials

Testimonial of a CRA monitoring trials in Spain

8 years working with ILife Consulting monitoring trials in oncology, rare diseases, cardiology, vaccines, neurology...

Testimonial of a CRA monitoring trials in Germany

CRA testimonials

Testimonial of a CRA monitoring trials in Germany

9 years working with ILife Consulting monitoring trials in oncology, cardiology, dermatology and neurology

Testimonial of a CRA monitoring trials in The Netherlands

CRA testimonials

Testimonial of a CRA monitoring trials in The Netherlands

8 years working with ILife Consulting monitoring trials in oncology (solid tumors & hematology), neurology, CNS, stroke, anesthesia...

Testimonial of a CRA monitoring trials in Greece

CRA testimonials

Testimonial of a CRA monitoring trials in Greece

8 years working with ILife Consulting monitoring trials in oncology (solid tumors and hematology) and transfusion-dependent blood disorders

TRAINING & UPSKILLING TO IMPROVE CLINICAL TRIAL OUTCOME

TRAINING & UPSKILLING TO IMPROVE CLINICAL TRIAL OUTCOME

An open-label, multicenter, non-randomized interventional roll over trial for relapsing glioblastoma patients

RESCUING AN EXTENSION PHASE

RESCUING AN EXTENSION PHASE

A randomized, double blind, multicentre, multinational, placebo controlled, single parallel escalating dose safety and efficacy study

Testimonials of some of our freelance CRAs

Testimonial of a CRA monitoring trials in Spain

Testimonial of a CRA monitoring trials in Spain

8 years working with ILife Consulting monitoring trials in oncology, rare diseases, cardiology, vaccines, neurology...

Testimonial of a CRA monitoring trials in Germany

Testimonial of a CRA monitoring trials in Germany

9 years working with ILife Consulting monitoring trials in oncology, cardiology, dermatology and neurology

Testimonial of a CRA monitoring trials in The Netherlands

Testimonial of a CRA monitoring trials in The Netherlands

8 years working with ILife Consulting monitoring trials in oncology (solid tumors & hematology), neurology, CNS, stroke, anesthesia...

bottom of page